OmniAb, Inc.
NASDAQ:OABI
Overview | Financials
Company Name | OmniAb, Inc. |
Symbol | OABI |
Currency | USD |
Price | 3.19 |
Market Cap | 386,030,130 |
Dividend Yield | 0% |
52-week-range | 3.19 - 6.549 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Matthew W. Foehr |
Website | https://www.omniab.com |
An error occurred while fetching data.
About OmniAb, Inc.
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD